Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[252Cf brachytherapy].

T Sugiyama, K Kaneta

    Gan No Rinsho. Japan Journal of Cancer Clinics
    |May 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Californium-252 brachytherapy shows promise for treating anoxic cancers like adenocarcinomas and melanomas. This fast neutron radiation therapy may be more effective than photon radiation, with an optimal dose of 12-18 Gy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Recalcitrant facial pemphigus vulgaris: correlation of skin lesions with the ratio of antidesmoglein antibodies 1 and 3.

    Clinical and experimental dermatology·2011
    Same author

    Allelic loss of chromosome 17p in urothelial cancer: strong association with invasive phenotype.

    The Journal of urology·1992
    Same author

    Molecular cloning of an alanine aminotransferase from NAD-malic enzyme type C4 plant Panicum miliaceum.

    Plant molecular biology·1992
    Same author

    Epoxomicin, a new antitumor agent of microbial origin.

    The Journal of antibiotics·1992
    Same author

    [A case of chronic fatigue syndrome who showed a beneficial effect by intravenous administration of magnesium sulphate].

    Arerugi = [Allergy]·1992
    Same author

    Study on neutralization of low molecular weight heparin (LHG) by protamine sulfate and its neutralization characteristics.

    Thrombosis research·1992
    Same journal

    [A neuron-specific enolase (NSE) positive leiomyosarcoma].

    Gan no rinsho. Japan journal of cancer clinics·1990
    Same journal

    [A case of synchronous multiple primary cancers of the stomach and kidney].

    Gan no rinsho. Japan journal of cancer clinics·1990
    Same journal

    [A case of multiple peripheral pulmonary carcinoids showing a diffuse lung disease synchronously associated with sigmoid colon cancer].

    Gan no rinsho. Japan journal of cancer clinics·1990
    Same journal

    [A well differentiated fibrosarcoma arising in left neck region].

    Gan no rinsho. Japan journal of cancer clinics·1990
    Same journal

    [A giant struma histologically confirmed as a medullary carcinoma with multiple systemic bone metastasis].

    Gan no rinsho. Japan journal of cancer clinics·1990
    Same journal

    [Problems associated with radical neck dissection in patients with tongue carcinoma: four cases of stage I tongue carcinoma that recurred in the cervical area after the dissection].

    Gan no rinsho. Japan journal of cancer clinics·1990
    See all related articles

    Area of Science:

    • Medical Physics
    • Radiation Oncology
    • Nuclear Medicine

    Context:

    • Brachytherapy is a localized radiation treatment.
    • Californium-252 offers a unique fast neutron radiation source.
    • Anoxic tissues present challenges for conventional photon therapy.

    Purpose:

    • To evaluate the efficacy of Californium-252 brachytherapy.
    • To compare Californium-252 fast neutron therapy with photon radiation.
    • To determine optimal dosimetry for Californium-252 treatment.

    Summary:

    • Californium-252 brachytherapy was used in 117 cases (mold, interstitial, intracavitary).
    • Effective for differentiated adenocarcinomas, malignant melanomas, and recurrent cancers in anoxic scar tissues.
    • Optimal absorbed neutron dose is 12-18 Gy, adjusted for normal tissue tolerance.

    Related Experiment Videos

    Impact:

    • Californium-252 provides a potentially superior treatment option for specific radioresistant tumors.
    • Highlights the need for individualized dosimetry considering normal tissue response to fast neutrons.
    • Contributes to understanding the clinical applications of Californium-252 in cancer therapy.